跳至主要内容
临床试验/TCTR20201106003
TCTR20201106003招募中未知

Immature platelet fraction values predict platelet recovery following consolidation chemotherapy in AML patient

Siriraj Hospital Mahidol University0 个研究点目标入组 41 人开始时间: 2020年11月6日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
41

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • The patients older than 18 years with acute myeloid leukemia after receiving periodic chemotherapy consolidation with HiDAC or IDAC formulations

排除标准

  • The patients with disseminated intravascular coagulation (DIC), thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), immune thrombocytopenia (ITP), or systemic lupus erythematosus (SLE) with exacerbation.
  • Patients with hypersplenism.
  • Diagnosed with abnormal bone marrow platelet production, including aplastic anemia (AA), myelodysplastic syndrome (MDS).

研究者

发起方
Siriraj Hospital Mahidol University

相似试验